We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-6.6%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$24.5B
AUM Growth
-$1.55B
Cap. Flow
+$503M
Cap. Flow %
2.05%
Top 10 Hldgs %
14.23%
Holding
2,483
New
111
Increased
1,136
Reduced
972
Closed
225

Sector Composition

Rank Sector Weight
1 Healthcare 9.12%
2 Technology 8.89%
3 Financials 8.43%
4 Consumer Staples 7.6%
5 Industrials 6.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FNY icon
2076
First Trust Mid Cap Growth AlphaDEX Fund
FNY
$604M
$345K ﹤0.01%
+12,281
New +$370K
LXP icon
2077
LXP Industrial Trust
LXP
$3.57B
$345K ﹤0.01%
8,524
-1,126
-12% -$47.5K
ESV
2078
DELISTED
Ensco Rowan plc
ESV
$345K ﹤0.01%
6,134
-18,810
-75% -$1.3M
BKK
2079
DELISTED
Blackrock Municipal 2020 Term Trust
BKK
$344K ﹤0.01%
+21,902
New +$342K
MUA icon
2080
BlackRock MuniAssets Fund
MUA
$522M
$343K ﹤0.01%
25,394
-13,811
-35% -$189K
RMTI icon
2081
Rockwell Medical
RMTI
$28.2M
$343K ﹤0.01%
404
-1,134
-74% -$1.64M
MPA icon
2082
BlackRock MuniYield Pennsylvania Quality Fund
MPA
$144M
$341K ﹤0.01%
25,096
SHYF
2083
DELISTED
The Shyft Group
SHYF
$340K ﹤0.01%
82,412
RFI
2084
Cohen & Steers Total Return Realty Fund
RFI
$310M
$337K ﹤0.01%
28,343
+5,551
+24% +$68.4K
RGEN icon
2085
Repligen
RGEN
$9.25B
$337K ﹤0.01%
12,095
-708
-6% -$25.6K
ACOR
2086
DELISTED
Acorda Therapeutics
ACOR
$337K ﹤0.01%
106
+9
+9% +$34.9K
NFJ
2087
Virtus Dividend, Interest & Premium Strategy Fund
NFJ
$1.43B
$333K ﹤0.01%
26,052
-2,045
-7% -$28.4K
PGZ
2088
Principal Real Estate Income Fund
PGZ
$68.7M
$331K ﹤0.01%
19,200
-4,000
-17% -$71.1K
IPG
2089
DELISTED
Interpublic Group of Companies
IPG
$330K ﹤0.01%
+17,229
New +$344K
DF
2090
DELISTED
Dean Foods Company
DF
$330K ﹤0.01%
19,946
+1,615
+9% +$27.6K
CXP
2091
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
$328K ﹤0.01%
14,129
-1,225
-8% -$28.7K
SBRA icon
2092
Sabra Healthcare REIT
SBRA
$5.37B
$327K ﹤0.01%
14,115
-1,750
-11% -$44.7K
FMO
2093
DELISTED
Fiduciary/Claymore Energy Infrastructure Fund
FMO
$326K ﹤0.01%
4,175
-201
-5% -$19.9K
HHY
2094
DELISTED
Brookfield High Income Fund Inc.
HHY
$326K ﹤0.01%
44,696
-6,221
-12% -$47.9K
HZO icon
2095
MarineMax
HZO
$788M
$324K ﹤0.01%
22,905
-1,081
-5% -$19K
IXC icon
2096
iShares Global Energy ETF
IXC
$2.62B
$324K ﹤0.01%
11,287
-2,521
-18% -$79.3K
VECO icon
2097
Veeco
VECO
$3.23B
$324K ﹤0.01%
15,812
+535
+4% +$12.9K
SLCA
2098
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$324K ﹤0.01%
22,995
-17,204
-43% -$367K
PEBK icon
2099
Peoples Bancorp of North Carolina
PEBK
$229M
$323K ﹤0.01%
20,326
BEP icon
2100
Brookfield Renewable
BEP
$9.96B
$322K ﹤0.01%
21,918
+1,502
+7% +$22.4K

Similar funds

Raymond James & Associates's Q3 2015 Portfolio in Review

As of Q3 2015, Raymond James & Associates held 2,483 positions worth $24.5B, down 5.9% from $26.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Raymond James & Associates's Q3 2015 filing shows 111 new, 1,136 increased, 972 reduced and 225 closed positions. Its largest new stake was Camden Property Trust: 204,814 shares worth $15.1M. The largest sale was KRAFT FOODS GROUP INC COM STK (VA), an estimated $138M.

By sector, the portfolio is most concentrated in Healthcare at 9.1% of assets, down from 9.2% a quarter earlier, followed by Technology and Financials.

  • Raymond James & Associates's largest Q3 2015 buy was Camden Property Trust: 204,814 shares worth $15.1M.
  • Raymond James & Associates added most to ExxonMobil in Q3 2015, an estimated $88.7M increase.
  • Raymond James & Associates's biggest Q3 2015 reduction was TotalEnergies, cutting an estimated $63.3M.
  • Raymond James & Associates fully exited KRAFT FOODS GROUP INC COM STK (VA) in Q3 2015, selling an estimated $138M.
  • Raymond James & Associates's ten largest holdings make up 14% of its $24.5B portfolio in Q3 2015.
  • Raymond James & Associates opened 111 new positions and closed 225 in Q3 2015.
  • Raymond James & Associates's portfolio value fell 5.9% quarter-over-quarter to $24.5B.

Based on Raymond James & Associates's 13F filing for Q3 2015, filed 13 Nov 2015.